INACTIVE/DISSOLVED
Address
Excalibur Fund Managers Ltd
Berkeley Square
Berkeley Square House
London
W1J 6BD
United Kingdom
Phone
Industry
VCID: 32746
Profile
Corporate information
Official name
Excalibur Fund Managers Ltd
Registration country
Official name
Excalibur Fund Managers Ltd
Registration country
Investment activity status
Not investing
Funds managed
| Fund | Type | Vintage |
|---|---|---|
| Merlin Biosciences Fund III LP | Venture | 2003 |
Investments
Selected investments
| Company | Country | Notes | ||
|---|---|---|---|---|
|
Biowisdom Ltd Knowledge management software for drug development. |
United Kingdom | N/A |
|
|
|
VivoMedica PLC Advancing medical devices from prototype to market. Reversal in to AIM listed company in July 2005. |
United Kingdom | N/A |
|
|
|
De Novo Pharmaceuticals Ltd A world leader in in-silico structure-based drug design, de novo drug design. |
United Kingdom | N/A |
|
|
|
PanTherix Ltd A start-up biotech specializing in antibiotic target validation and drug discovery. |
United Kingdom | N/A |
|
|
|
KinderTec Ltd Paediatric consumer healthcare products. Trade sale in December 2005. |
United Kingdom | N/A |
|
|
|
Decon Sciences Ltd Decontamination services provider |
United Kingdom | N/A |
|
|
|
York Pharma PLC Acquisition, development and commercialisation of prescription dermatological products. |
United Kingdom | N/A |
|
|
Emergent BioSolutions Inc Research, development and manufacture of novel vaccines and related products IPO in November 2006. Fully disposed. |
United States | N/A |
|
|
|
Paradigm Therapeutics Ltd Drug discovery platform company Acquired by Takeda Pharmaceutical Company Ltd in December 2004. |
United Kingdom | N/A |
|
|
|
Microscience Investments Ltd Vaccines for typhoid, travellers’ illnesses and hepatitis B Merged with NASDAQ listed Emergent Biosolutions Inc in July 2005. |
United Kingdom | N/A |
|
|
|
DestinationSkin Ltd Skin treatment and hair removal. |
United Kingdom | N/A |
|
|
|
Amura Ltd A structure-based drug discovery business specialising in diseases such as osteoporosis, osteoarthritis, bone metasta. Secondary sale in February 2005 |
United Kingdom | N/A |
|
|
|
EpiCept Inc Topical pain management. IPO in January 2006. |
United States | N/A |
|
|
|
ReNeuron Group PLC Treatments for neurological disorders. IPO in August 2005 |
United Kingdom | N/A |
|
|
|
Biovex Inc Biotechnology company developing new generation biologics for the treatment of cancer and infectious disease. |
United States | N/A Active |
|
|
|
Energist Ltd Manufactures and markets lasers and light-based systems for hair removal and aesthetic skin treatments, serving both the medical and beauty sectors. |
United Kingdom | N/A |
|
|
|
Ardana PLC Drugs for reproductive disorders and hormone sensitive cancers. IPO in March 2005. |
United Kingdom | N/A |
|
|
|
Intercytex Group PLC A UK Regenerative Medicine Company product and services. IPO in February 2006. Presently known as Regenerative Medicine Assets Ltd. |
United Kingdom | N/A |
|
|
|
Santhera Pharmaceuticals AG Small molecule therapeutics for neuromuscular and metabolic diseases. IPO in November 2006. |
Switzerland | N/A |
|
|
|
Lab21 Ltd |
United Kingdom | N/A |